🧠AI AnalysisLiquidia Retains Pulmonary Arterial Hypertension Portfolio Following Legal Settlement
Liquidia Corporation maintained ownership of its Yutrepia pulmonary arterial hypertension franchise after resolving legal disputes with United Therapeutics.